Untargeted Metabolomic Analysis of Human Plasma Indicates Differentially Affected Polyamine and L-Arginine Metabolism in Mild Cognitive Impairment Subjects Converting to Alzheimer’s Disease

Rapidly improved determination of metabolites from biological data sets using the high-efficient TransOmics tool

(2014) Aihua Zhang et al.   Molecular BioSystems

A new metabolomic workflow for early detection of Alzheimer's disease

(2013) Clara Ibáñez et al.   JOURNAL OF CHROMATOGRAPHY A

Glucose Levels and Risk of Dementia

(2013) Paul K. Crane et al.   NEW ENGLAND JOURNAL OF MEDICINE

Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using Metabolomics

(2013) Eugenia Trushina et al.   PLoS One

Metabolic profiling of Alzheimer's disease brains

(2013) Koichi Inoue et al.   Scientific Reports

Alterations in metabolic pathways and networks in Alzheimer’s disease

(2013) R Kaddurah-Daouk et al.   Translational Psychiatry

Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer’s disease from normal cognitive aging

(2013) Alison A Motsinger-Reif et al.   Acta Neuropathologica Communications

Investigation of the Human Brain Metabolome to Identify Potential Markers for Early Diagnosis and Therapeutic Targets of Alzheimer’s Disease

(2012) Stewart F. Graham et al.   ANALYTICAL CHEMISTRY

The link between altered cholesterol metabolism and Alzheimer's disease

(2012) Paola Gamba et al.   Annals of the New York Academy of Sciences

Neuropsychological measures predict decline to Alzheimer's dementia from mild cognitive impairment.

(2012) Mathew J. Summers et al.   NEUROPSYCHOLOGY

Biomarkers of Alzheimer′s Disease in the Cerebrospinal Fluid of Spanish Patients With Mild Cognitive Impairment

(2011) J. A. Monge-Argilés et al.   NEUROCHEMICAL RESEARCH

Metabolome in progression to Alzheimer's disease

(2011) M Orešič et al.   Translational Psychiatry

Carbon-11-Pittsburgh compound B positron emission tomography imaging of amyloid deposition in presenilin 1 mutation carriers

(2010) William D. Knight et al.   BRAIN

Global metabolic profiling procedures for urine using UPLC–MS

(2010) Elizabeth J Want et al.   Nature Protocols

A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease

(2010) Reza M. Salek et al.   NEUROCHEMISTRY INTERNATIONAL

Genetic Evidence Implicates the Immune System and Cholesterol Metabolism in the Aetiology of Alzheimer's Disease

(2010) Lesley Jones et al.   PLoS One

Rate of progression of mild cognitive impairment to dementia - meta-analysis of 41 robust inception cohort studies

(2009) A. J. Mitchell et al.   ACTA PSYCHIATRICA SCANDINAVICA

Brain Neurons Express Ornithine Decarboxylase-Activating Antizyme Inhibitor 2 with Accumulation in Alzheimer's Disease

(2009) Laura T. Mäkitie et al.   BRAIN PATHOLOGY

Two-year outcome of MCI subtypes and aetiologies in the Goteborg MCI study

(2009) A. Nordlund et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Metabonomic Characterization of the 3-Nitropropionic Acid Rat Model of Huntington’s Disease

(2009) T. M. Tsang et al.   NEUROCHEMICAL RESEARCH

Selectivity of executive function deficits in mild cognitive impairment.

(2009) Jason Brandt et al.   NEUROPSYCHOLOGY

The Role of Arginine–Nitric Oxide Pathway in Patients with Alzheimer Disease

(2008) Huseyin Vural et al.   BIOLOGICAL TRACE ELEMENT RESEARCH

Diabetes and other vascular risk factors for dementia: Which factor matters most? A systematic review

(2008) Raoul P. Kloppenborg et al.   EUROPEAN JOURNAL OF PHARMACOLOGY